VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
CVSCVS Health Corporation
$100.68$128.5B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCVSRevenue History

CVS logoCVS Health Corporation (CVS) Revenue History

Annual and quarterly revenue from 1989 to present

TTM Revenue$407.90B▲ +$5.84B vs FY2025
YoY Growth+6.2%Solid
Q1 2026$100.43B+6.2% YoY · -5.0% QoQ
Revenue CAGR
3Y+7.6%
→
5Y+8.4%
→
10Y+10.1%
Solid
Best Fiscal Year$402.07B (2025)
Best Quarter$105.69B (Q4 2025)
Revenue per Share$319.69
Revenue per Employee$1.4M

CVS Revenue Over Time (1989–2025)

CVS Revenue Growth History

34 of 36 years with positive growth
Annual Revenue Growth · Each cell = one fiscal year
1989—
1990+15.0%
1991+13.8%
1992+5.5%
1993+0.0%
1994+8.1%
1995-13.5%
1996+21.2%
1997+16.2%
1998+11.1%
1999+18.5%
2000+11.0%
2001+10.7%
2002+8.7%
2003+10.0%
2004+15.1%
2005+21.0%
2006+18.4%
2007+74.2%
2008+14.6%
2009+12.3%
2010-2.5%
2011+11.8%
2012+15.0%
2013+3.0%
2014+9.9%
2015+10.0%
2016+15.8%
2017+4.1%
2018+5.3%
2019+32.0%
2020+4.6%
2021+8.7%
2022+10.4%
2023+10.9%
2024+4.2%
2025+7.8%
FY1989 revenue growth
N/A
FY1990 revenue growth
+15.0%
FY1991 revenue growth
+13.8%
FY1992 revenue growth
+5.5%
FY1993 revenue growth
+0.0%
FY1994 revenue growth
+8.1%
FY1995 revenue growth
-13.5%
FY1996 revenue growth
+21.2%
FY1997 revenue growth
+16.2%
FY1998 revenue growth
+11.1%
FY1999 revenue growth
+18.5%
FY2000 revenue growth
+11.0%
FY2001 revenue growth
+10.7%
FY2002 revenue growth
+8.7%
FY2003 revenue growth
+10.0%
FY2004 revenue growth
+15.1%
FY2005 revenue growth
+21.0%
FY2006 revenue growth
+18.4%
FY2007 revenue growth
+74.2%
FY2008 revenue growth
+14.6%
FY2009 revenue growth
+12.3%
FY2010 revenue growth
-2.5%
FY2011 revenue growth
+11.8%
FY2012 revenue growth
+15.0%
FY2013 revenue growth
+3.0%
FY2014 revenue growth
+9.9%
FY2015 revenue growth
+10.0%
FY2016 revenue growth
+15.8%
FY2017 revenue growth
+4.1%
FY2018 revenue growth
+5.3%
FY2019 revenue growth
+32.0%
FY2020 revenue growth
+4.6%
FY2021 revenue growth
+8.7%
FY2022 revenue growth
+10.4%
FY2023 revenue growth
+10.9%
FY2024 revenue growth
+4.2%
FY2025 revenue growth
+7.8%
DeclineStrong growth
↑ 15-year growth streakBest: +74.2% (FY2007)Worst: -13.5% (FY1995)
Recent Quarterly Revenue & YoY Growth
QuarterRevenueYoY
Q1 2026$100.43B+6.2%
Q4 2025$105.69B+8.2%
Q3 2025$102.87B+7.8%
Q2 2025$98.92B+8.4%
Q1 2025$94.59B+7.0%
Q4 2024$97.71B+4.2%
Q3 2024$95.43B+6.3%
Q2 2024$91.23B+2.6%
Seasonal Revenue Pattern (fiscal quarters)
Q1
23%
Q2
25%
Q3
25%
Q4
27%

Multi-year avg. share of annual revenue by fiscal quarter

Revenue Breakdown (FY 2025)

CVS's revenue distribution by segment and geography for fiscal year 2025

By Product/Segment

Pharmacy Revenue58.9%
Premiums34.6%
Front Store Revenue5.5%
Product and Service, Other1.0%

CVS Revenue Analysis (1989–2025)

Current Revenue & Growth

As of June 16, 2026, CVS Health Corporation (CVS) generated trailing twelve-month (TTM) revenue of $407.90 billion, reflecting solid growth of +6.2% year-over-year. The most recent quarter (Q1 2026) recorded $100.43 billion in revenue, down 5.0% sequentially.

Historical Growth Trajectory

CVS's 5-year compound annual growth rate (CAGR) stands at +8.4%, indicating steady revenue expansion. The 3-year CAGR of +7.6% is below the 5-year average, signalling a growth deceleration in recent years. CVS Health Corporation's highest annual revenue of $402.07 billion was recorded in 2025, an all-time high.

Revenue by Segment

CVS's revenue is primarily driven by Pharmacy Revenue (59%), Premiums (35%), and Front Store Revenue (6%). With over half of revenue concentrated in Pharmacy Revenue, the company has a focused business model while developing other growth vectors.

Peer Comparison

Compared to Healthcare sector peers — including UNH (+9.7% YoY), CI (+8.8% YoY), and ELV (+9.4% YoY) — CVS has underperformed the peer group in revenue growth. Compare CVS vs UNH →

CVS Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
CVS logoCVSCurrent$407.9B+6.2%+8.4%2.6%
UNH logoUNH$447.6B+9.7%+11.7%4.2%
CI logoCI$275.0B+8.8%+11.4%3.3%
ELV logoELV$199.1B+9.4%+10.3%4.1%
HUM logoHUM$129.7B+14.1%+10.9%1.1%
MCK logoMCK$403.4B+12.4%+11.1%1.6%
Best in groupLowest in group

CVS Historical Revenue Data (1989–2025)

1–15 of 37 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$402.07B+7.8%$55.36B13.8%$10.38B2.6%
2024$372.81B+4.2%$51.40B13.8%$8.52B2.3%
2023$357.78B+10.9%$54.43B15.2%$13.74B3.8%
2022$322.47B+10.4%$54.50B16.9%$7.95B2.5%
2021$292.11B+8.7%$52.12B17.8%$13.31B4.6%
2020$268.71B+4.6%$49.05B18.3%$13.91B5.2%
2019$256.78B+32.0%$45.53B17.7%$11.99B4.7%
2018$194.58B+5.3%$31.54B16.2%$4.02B2.1%
2017$184.79B+4.1%$28.53B15.4%$9.54B5.2%
2016$177.55B+15.8%$28.83B16.2%$10.39B5.8%
2015$153.29B+10.0%$26.53B17.3%$9.47B6.2%
2014$139.37B+9.9%$25.37B18.2%$8.80B6.3%
2013$126.76B+3.0%$23.78B18.8%$8.04B6.3%
2012$123.12B+15.0%$22.49B18.3%$7.21B5.9%
2011$107.08B+11.8%$20.56B19.2%$6.33B5.9%

Full CVS Stock Analysis

Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.

View Analysis

What if you invested $1,000 in CVS back in 1989?

Total return with dividends reinvested · 37+ years of data

Calculate Returns

How much would $100/month in CVS be worth today?

Dollar cost averaging vs lump sum · see how regular investing compounds over time

Run the Numbers

Is CVS Undervalued Right Now?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

CVS vs LLY — which is the better buy?

Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.

Compare Now

CVS — Frequently Asked Questions

Quick answers to the most common questions about buying CVS stock.

Is CVS's revenue growth accelerating or slowing?

CVS revenue growth is holding steady at +6.2% year-over-year. TTM revenue is $407.9B. The current growth rate closely tracks the 5-year CAGR of +8.4%, signalling consistent execution.

What is CVS's revenue history from 1989 to 2026?

CVS Health Corporation (CVS) revenue history spans 1989 to 2026. TTM revenue as of 2026 is $407.9B, growing at +6.2% YoY. The 5-year CAGR is +8.4%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.

What is CVS's long-term revenue growth rate (CAGR)?

CVS Health Corporation's 5-year revenue CAGR of +8.4% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +6.2% is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for CVS.

Why does CVS's quarterly revenue fluctuate?

CVS quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. CVS Health Corporation's revenue data from 1989 to 2026 shows full historical quarterly detail on this page.

How is CVS's revenue distributed by segment?

CVS reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.

How does CVS's revenue compare to industry peers?

CVS Health Corporation (CVS) with TTM revenue of $407.9B and +6.2% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.